SARTORIUS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.8 EUR | -0.97% |
|
-7.24% | -13.02% |
| 01:23pm | SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg | ZD |
| Apr. 23 | SARTORIUS VORZUEGE : DZ Bank gives a Sell rating | ZD |
Presenter SpeechLothar Kappich (Executives)Hello, dear ladies and gentlemen. My name is Lothar...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
2024-05-16
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
291.7
EUR
Average target price
336.8
EUR
Spread / Average Target
+15.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -45.18% | 2.7B | |
| +15.62% | 1.83B | |
| -2.14% | 1.63B | |
| +22.36% | 1.2B | |
| -13.27% | 995M | |
| -21.67% | 896M | |
| -5.82% | 726M | |
| -15.76% | 701M | |
| +13.44% | 527M |
- Stock Market
- Equities
- SRT3 Stock
- SRT Stock
- News Sartorius AG
- Transcript : Sartorius Aktiengesellschaft - Shareholder/Analyst Call
